keyboard_arrow_up

Healthcare/Medical simulation Market worth $2,069.2 Million by 2019 - CAE, Inc. (Canada), Laerdal Medical AS (Norway), 3D Systems, Inc. (U.S.), Simulab Corporation (U.S.), Simulaids, Inc. (U.S.), Limbs and Things, Ltd (U.K.), Kyoto Kagaku Co., Ltd (Japan), Mentice AB (Sweden), Surgical Science Sweden AB (Sweden), and Gaumard Scientific Company, Inc. (U.S.).

According to the new market research report the “Healthcare/Medical simulation Market – by Product (Patient Simulator, Surgical Simulator, Web-based Simulation, Simulation Software, Dental Simulator, Eye Simulator), End-User (Academics, Hospitals, Military), & Services - Global Forecasts to 2019”, published by marketsandmarkets, analyzes and studies the major market drivers, restraints, opportunities, challenges, and burning issues in North America, Europe, Asia-Pacific, and the Rest of the World.

Early buyers will receive 10% customization on this report.

This report studies the Healthcare/Medical Simulation Market over the forecast period of 2014 to 2019.

Healthcare/medical simulation improves patient outcomes, facilitates increased task proficiency and patient safety, reduces medical errors, and enhances professional communication and team management skills, which reduces the overall healthcare costs. Therefore, an increased number of medical schools, training centers, and military organizations are adopting simulation technologies. In addition, there is an increasing adoption of technologically advanced simulation systems to create clinical condition situations so that the actual operations on patients can be done with minimized errors. However, high costs of simulators, limited availability of funds, and operational challenges may restrain the growth of this market during the forecast period of 2014 to 2019.

Further Inquiry: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1156

In this report, the Healthcare/Medical Simulation Market is segmented on the basis of different types of products and services, end users, and regions. This report also discusses the key market drivers, restraints, opportunities, and challenges for this market and its submarkets. The global Healthcare/Medical Simulation Market is expected to reach $2,069.2 million by 2019 from $863.5 million in 2014 and, at a CAGR of 19.1% from 2014 to 2019.

In 2013, North America was the major market for healthcare/medical simulation products and services, followed by Europe and Asia-Pacific. The highest market share of North America and European regions is primarily attributed to the presence and expansion of major healthcare/medical simulation companies through acquisitions which has improved the accessibility of healthcare/medical simulation products and services in this region. However, the future growth of the Healthcare/Medical Simulation Market will be driven by the Asia-Pacific and Latin American regions. This is mainly attributed to the continuous efforts of Asian economies toward the development of the healthcare sector in this region. These economies have modified regulations and monitored the implementation of procedures, policies, and guidelines to promote innovation and commercialization. This is attracting many homegrown entrepreneurs as well as global leaders to the region. The increasing number of hospitals, academic institutions, and medical devices propel the market for healthcare/medical simulation. Moreover, increasing focus on medical education, training, and research in India and China showcases great potential for the Healthcare/Medical Simulation Market in this region.

To Purchase: http://www.marketsandmarkets.com/Purchase/purchase_report1.asp?id=1156

The major players in the Healthcare/Medical Simulation Market are CAE, Inc. (Canada), Laerdal Medical AS (Norway), 3D Systems, Inc. (U.S.), Simulab Corporation (U.S.), Simulaids, Inc. (U.S.), Limbs and Things, Ltd (U.K.), Kyoto Kagaku Co., Ltd (Japan), Mentice AB (Sweden), Surgical Science Sweden AB (Sweden), and Gaumard Scientific Company, Inc. (U.S.).

  About MarketsandMarkets

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan

North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com